Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells for severe post-allogeneic transplant hemorrhagic cystitis
2010-022988-35Phase 2Terminated
- Sponsor
- Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
- Start
- Jan 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bone marrow-derived mesenchymal stem cells in hemorrhagic cystitis (HC), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Primary endpoint: Clinical response. Started Jan 2011; status: terminated.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
hemorrhagic cystitis (HC)
Beyond the preview
Go deeper on 2010-022988-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022988-35.